Dantari

About:

Developer of a pharmaceutical platform and drugs created for the treatment of the central nervous system.

Website: https://dantari.com/

Top Investors: Alexandria Venture Investments, Caltech, Corner Ventures, Westlake Village BioPartners

Description:

Developer of a pharmaceutical platform and drugs created for the treatment of the central nervous system. The company's platform and therapies specialize in the research and development of small and large molecule therapeutics across the blood-brain barrier, enabling clients to have rapidly advance therapies to treat the patients and provide meaningful medical improvement in their lives.

Total Funding Amount:

$47M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Thousand Oaks, California, United States

Founded Date:

2018-01-01

Founders:

Richard Markus

Number of Employees:

11-50

Last Funding Date:

2022-12-08

IPO Status:

Private

Industries:

© 2025 bioDAO.ai